[Clinical aspects of the polymorphism of oxidation phenotype].
Mrozikiewicz
P M
PM
Kliniki Nadciśnienia Tetniczego, Instytutu Kardiologii AM w Poznaniu.
D001711:Biotransformation / Q000502:physiology; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D003647:Debrisoquin / Q000493:pharmacokinetics* / Q000652:urine; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008954:Models, Biological; D008957:Models, Genetic; D010084:Oxidation-Reduction; D010641:Phenotype; D011110:Polymorphism, Genetic; D013034:Sparteine / Q000493:pharmacokinetics* / Q000652:urine
D013034:Sparteine; D003577:Cytochrome P-450 Enzyme System; D003647:Debrisoquin
Kliniczne aspekty polimorfizmu fenotypu utleniania.